Results 181 to 190 of about 75,344 (250)

A novel LL-37@NH2@Fe3O4 inhibits the proliferation of the leukemia K562 cells: in-vitro study. [PDF]

Sci Rep
Habibi A, Davari A, Isazadeh K.
europepmc   +1 more source

Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide. [PDF]

J Pharmacol Exp Ther, 2023
Carvajal-Moreno J, Hernandez VA, Wang X, Li J, Yalowich JC, Elton TS.   +5 more
europepmc   +1 more source

Protocol for optimizing surface expression and speed in coaggregation assays using K562 cells and subsequent analysis with a CoAg Index. [PDF]

STAR Protoc
Bisogni AJ, Armstead BL, Lin DM.
europepmc   +1 more source

Cell cycle arrest explains the observed bulk 3D genomic alterations in response to long-term heat shock in K562 cells. [PDF]

Genome Res, 2022
Xu B, Gao X, Li X, Jia Y, Li F, Zhang Z.
europepmc   +1 more source

CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression. [PDF]

Exp Ther Med
Dai C, Cui X, Wang J, Dong B, Gao H, Cheng M, Jiang F.   +6 more
europepmc   +1 more source

Circumvention of Topoisomerase II<i>α</i> Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. [PDF]

Mol Pharmacol
Wang X, Carvajal-Moreno J, Zhao X, Li J, Hernandez VA, Yalowich JC, Elton TS.   +6 more
europepmc   +1 more source

8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells. [PDF]

Biomedicines, 2021
Wu PS, Wang CY, Chen PS, Hung JH, Yen JH, Wu MJ.   +5 more
europepmc   +1 more source

Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II<i>β</i> in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. [PDF]

J Pharmacol Exp Ther
Carvajal-Moreno J, Wang X, Hernandez VA, Mondal M, Zhao X, Yalowich JC, Elton TS.   +6 more
europepmc   +1 more source

Bioinformatics of Differentially Expressed Genes in Phorbol 12-Myristate 13-Acetate-Induced Megakaryocytic Differentiation of K562 Cells by Microarray Analysis. [PDF]

Int J Mol Sci, 2022
Lee SH, Park NR, Kim JE.
europepmc   +1 more source

Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells. [PDF]

Mol Med Rep, 2021
Li J, Wang X, Ma C, Xu S, Xu M, Yang J, Wang R, Xue L.   +7 more
europepmc   +1 more source